COVID-19
Biosimilars
Cataract Therapeutics
DME
Gene Therapy
Workplace
Ptosis
Optic Relief
Imaging
Geographic Atrophy
AMD
Presbyopia
Ocular Surface Disease
Practice Management
Pediatrics
Surgery
Therapeutics
Optometry
Retina
Cataract
Pharmacy
IOL
Dry Eye
Understanding Antibiotic Resistance
Refractive
Cornea
Glaucoma
OCT
Ocular Allergy
Clinical Diagnosis
Technology

Mitomycin-C after surface ablation can prevent corneal haze

March 1, 2004

Article

Anaheim, CA-Mitomycin-C (MMC), a potent radiomimetic compound, is a useful treatment to prevent corneal haze after surface ablation in patients undergoing PRK who have greater than -7 D of myopia or an ablation depth greater than 75 ?m. It is also a good option for patients who develop late-onset haze after refractive surgery and those who have complications such as buttonholes or partial flaps after attempted LASIK, according to Randy J. Epstein, MD, who spoke during the International Society of Refractive Surgery/American Academy of Ophthalmology refractive surgery subspecialty day meeting.